Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026763255> ?p ?o ?g. }
- W2026763255 endingPage "230" @default.
- W2026763255 startingPage "219" @default.
- W2026763255 abstract "Thirty-nine tumor-bearing patients with metastatic melanoma were treated with 3 subcutaneous injections of the MAGE-3.A1 peptide at monthly intervals. No significant toxicity was observed. Of the 25 patients who received the complete treatment, 7 displayed significant tumor regressions. All but one of these regressions involved cutaneous metastases. Three regressions were complete and 2 of these led to a disease-free state, which persisted for more than 2 years after the beginning of treatment. No evidence for a cytolytic T lymphocyte (CTL) response was found in the blood of the 4 patients who were analyzed, including 2 who displayed complete tumor regression. Our results suggest that injection of the MAGE-3.A1 peptide induced tumor regression in a significant number of the patients, even though no massive CTL response was produced. Int. J. Cancer 80:219–230, 1999. © 1999 Wiley-Liss, Inc." @default.
- W2026763255 created "2016-06-24" @default.
- W2026763255 creator A5002644565 @default.
- W2026763255 creator A5007375349 @default.
- W2026763255 creator A5008205272 @default.
- W2026763255 creator A5008459225 @default.
- W2026763255 creator A5012625053 @default.
- W2026763255 creator A5012666922 @default.
- W2026763255 creator A5018131884 @default.
- W2026763255 creator A5019779356 @default.
- W2026763255 creator A5020481714 @default.
- W2026763255 creator A5030556396 @default.
- W2026763255 creator A5043631226 @default.
- W2026763255 creator A5048921562 @default.
- W2026763255 creator A5049106859 @default.
- W2026763255 creator A5053168505 @default.
- W2026763255 creator A5058125456 @default.
- W2026763255 creator A5058912347 @default.
- W2026763255 creator A5060553987 @default.
- W2026763255 creator A5061457653 @default.
- W2026763255 creator A5062210857 @default.
- W2026763255 creator A5075657141 @default.
- W2026763255 creator A5081718657 @default.
- W2026763255 creator A5082245754 @default.
- W2026763255 creator A5087548084 @default.
- W2026763255 creator A5088672360 @default.
- W2026763255 creator A5089784419 @default.
- W2026763255 date "1999-01-18" @default.
- W2026763255 modified "2023-10-18" @default.
- W2026763255 title "Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1" @default.
- W2026763255 cites W1977273255 @default.
- W2026763255 cites W1983467545 @default.
- W2026763255 cites W1983806918 @default.
- W2026763255 cites W1984869659 @default.
- W2026763255 cites W1986126065 @default.
- W2026763255 cites W1998746346 @default.
- W2026763255 cites W1999774568 @default.
- W2026763255 cites W2001423442 @default.
- W2026763255 cites W2005599658 @default.
- W2026763255 cites W2006987944 @default.
- W2026763255 cites W2016198585 @default.
- W2026763255 cites W2036121435 @default.
- W2026763255 cites W2040074861 @default.
- W2026763255 cites W2063574986 @default.
- W2026763255 cites W2066964346 @default.
- W2026763255 cites W2144429525 @default.
- W2026763255 cites W2148368831 @default.
- W2026763255 cites W2161343890 @default.
- W2026763255 cites W2468037988 @default.
- W2026763255 cites W3021254998 @default.
- W2026763255 doi "https://doi.org/10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s" @default.
- W2026763255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9935203" @default.
- W2026763255 hasPublicationYear "1999" @default.
- W2026763255 type Work @default.
- W2026763255 sameAs 2026763255 @default.
- W2026763255 citedByCount "769" @default.
- W2026763255 countsByYear W20267632552012 @default.
- W2026763255 countsByYear W20267632552013 @default.
- W2026763255 countsByYear W20267632552014 @default.
- W2026763255 countsByYear W20267632552015 @default.
- W2026763255 countsByYear W20267632552016 @default.
- W2026763255 countsByYear W20267632552017 @default.
- W2026763255 countsByYear W20267632552018 @default.
- W2026763255 countsByYear W20267632552019 @default.
- W2026763255 countsByYear W20267632552020 @default.
- W2026763255 countsByYear W20267632552021 @default.
- W2026763255 countsByYear W20267632552022 @default.
- W2026763255 countsByYear W20267632552023 @default.
- W2026763255 crossrefType "journal-article" @default.
- W2026763255 hasAuthorship W2026763255A5002644565 @default.
- W2026763255 hasAuthorship W2026763255A5007375349 @default.
- W2026763255 hasAuthorship W2026763255A5008205272 @default.
- W2026763255 hasAuthorship W2026763255A5008459225 @default.
- W2026763255 hasAuthorship W2026763255A5012625053 @default.
- W2026763255 hasAuthorship W2026763255A5012666922 @default.
- W2026763255 hasAuthorship W2026763255A5018131884 @default.
- W2026763255 hasAuthorship W2026763255A5019779356 @default.
- W2026763255 hasAuthorship W2026763255A5020481714 @default.
- W2026763255 hasAuthorship W2026763255A5030556396 @default.
- W2026763255 hasAuthorship W2026763255A5043631226 @default.
- W2026763255 hasAuthorship W2026763255A5048921562 @default.
- W2026763255 hasAuthorship W2026763255A5049106859 @default.
- W2026763255 hasAuthorship W2026763255A5053168505 @default.
- W2026763255 hasAuthorship W2026763255A5058125456 @default.
- W2026763255 hasAuthorship W2026763255A5058912347 @default.
- W2026763255 hasAuthorship W2026763255A5060553987 @default.
- W2026763255 hasAuthorship W2026763255A5061457653 @default.
- W2026763255 hasAuthorship W2026763255A5062210857 @default.
- W2026763255 hasAuthorship W2026763255A5075657141 @default.
- W2026763255 hasAuthorship W2026763255A5081718657 @default.
- W2026763255 hasAuthorship W2026763255A5082245754 @default.
- W2026763255 hasAuthorship W2026763255A5087548084 @default.
- W2026763255 hasAuthorship W2026763255A5088672360 @default.
- W2026763255 hasAuthorship W2026763255A5089784419 @default.
- W2026763255 hasBestOaLocation W20267632551 @default.
- W2026763255 hasConcept C11171543 @default.
- W2026763255 hasConcept C121608353 @default.
- W2026763255 hasConcept C126322002 @default.